• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[肝门部胆管癌的临床病理因素及预后量表]

[Clinico-pathological factors and prognosis scale for portal cholangiocarcinoma].

作者信息

Zharikov Yu O, Kovalenko Yu A, Olifir A A, Kalinin D V, Czhao A V

机构信息

A.V. Vishnevsky Institute of Surgery, Moscow, Russia.

出版信息

Khirurgiia (Mosk). 2017(1):27-31. doi: 10.17116/hirurgia2017127-31.

DOI:10.17116/hirurgia2017127-31
PMID:28209950
Abstract

INTRODUCTION

The objective of this study was to derive a prognostic scale to predict overall survival (OS) after a curative resection of perihilar cholangiocarcinoma (PHC).

MATERIAL AND METHODS

The data of 55 patients with portal cholangiocarcinoma were analysed. Patients were treated at the A.V. Vishnevsky Institute of Surgery from 2011 to 2015. Surgical treatment after biliary decompression was performed in 37 (67.3%) patients. In the long-term period we observed 36 (97.3%) of the operated patients. The dependence of the OS of clinical and pathological factors of the tumor was analysed using mono- and multifactor regression analysis of Cox proportional hazards models for all operated patients.

RESULTS

Total 1-3-, 5-year survival rate was 75.1, 60.5, 37.7, 35% respectively. Significant prognostic factors (monofactorial analysis) include perineural (p=0,05) and vascular invasion (p=0,049), R1 resection (p=0,01), disease stage III or higher (p=0,03), invasion of SI liver (p=0,004), tumor cells differentiation degree (grade) 2 and higher (p=0,0006). Multifactor analysis revealed that the low OS have determined by perineural (p=0,05) and vascular invasion (p=0,008), the degree of differentiation of tumor cells (p=0,001), disease stage (p=0,05), surgical resection margin (p=0.0345). Developed method of predicting OS is a score of prognostic factors.

CONCLUSION

The scale of individual prognosis in patients PHC takes into account both clinical and histopathological tumor characteristics. This scale may be useful to optimize the individual treatment.

摘要

引言

本研究的目的是推导一种预后量表,以预测肝门部胆管癌(PHC)根治性切除术后的总生存期(OS)。

材料与方法

分析了55例肝门部胆管癌患者的数据。这些患者于2011年至2015年在A.V. 维什涅夫斯基外科研究所接受治疗。37例(67.3%)患者在胆道减压后接受了手术治疗。在长期随访中,我们观察了36例(97.3%)接受手术的患者。使用Cox比例风险模型对所有接受手术的患者进行单因素和多因素回归分析,以分析肿瘤的临床和病理因素对总生存期的影响。

结果

1年、3年、5年总生存率分别为75.1%、60.5%、37.7%、35%。显著的预后因素(单因素分析)包括神经周围侵犯(p = 0.05)、血管侵犯(p = 0.049)、R1切除(p = 0.01)、疾病分期III期或更高(p = 0.03)、侵犯肝S1段(p = 0.004)、肿瘤细胞分化程度2级及更高(p = 0.0006)。多因素分析显示,总生存期低由神经周围侵犯(p = 0.05)、血管侵犯(p = 0.008)、肿瘤细胞分化程度(p = 0.001)、疾病分期(p = 0.05)、手术切缘(p = 0.0345)决定。所开发的预测总生存期的方法是一个预后因素评分。

结论

PHC患者的个体预后量表考虑了肿瘤的临床和组织病理学特征。该量表可能有助于优化个体化治疗。

相似文献

1
[Clinico-pathological factors and prognosis scale for portal cholangiocarcinoma].[肝门部胆管癌的临床病理因素及预后量表]
Khirurgiia (Mosk). 2017(1):27-31. doi: 10.17116/hirurgia2017127-31.
2
Optimal indications for additional resection of the invasive cancer-positive proximal bile duct margin in cases of advanced perihilar cholangiocarcinoma.进展期肝门部胆管癌病例中,对浸润性癌阳性近端胆管切缘进行额外切除的最佳指征。
Ann Surg Oncol. 2015;22(6):1915-24. doi: 10.1245/s10434-014-4232-2. Epub 2014 Nov 18.
3
High-grade dysplasia/carcinoma in situ of the bile duct margin in patients with surgically resected node-negative perihilar cholangiocarcinoma is associated with poor survival: a retrospective study.手术切除淋巴结阴性肝门周围胆管癌患者胆管边缘高级别发育不良/原位癌与生存不良相关:一项回顾性研究。
J Hepatobiliary Pancreat Sci. 2017 Aug;24(8):456-465. doi: 10.1002/jhbp.481. Epub 2017 Jul 3.
4
[Klatskin tumor: long-term survival following surgery].[肝门部胆管癌:手术后的长期生存情况]
Chirurg. 2016 Jun;87(6):514-9. doi: 10.1007/s00104-016-0169-2.
5
Perihilar cholangiocarcinoma: A different concept for radical resection.肝门部胆管癌:根治性切除的新概念。
Surg Oncol. 2020 Jun;33:270-275. doi: 10.1016/j.suronc.2020.02.013. Epub 2020 Feb 17.
6
Prognostic factors and long-term outcomes of hilar cholangiocarcinoma: A single-institution experience in China.肝门部胆管癌的预后因素及长期结局:中国单中心经验
World J Gastroenterol. 2016 Feb 28;22(8):2601-10. doi: 10.3748/wjg.v22.i8.2601.
7
Concomitant hepatic artery resection for advanced perihilar cholangiocarcinoma: a case-control study with propensity score matching.晚期肝门部胆管癌同期肝动脉切除术:一项倾向评分匹配的病例对照研究
J Hepatobiliary Pancreat Sci. 2016 Jul;23(7):442-8. doi: 10.1002/jhbp.363. Epub 2016 Jun 9.
8
Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.肝内胆管癌根治性切除术后的分期、预后因素及辅助治疗
Liver Int. 2014 Jul;34(6):953-60. doi: 10.1111/liv.12364. Epub 2013 Nov 20.
9
Prognostic impact of the site of portal vein invasion in patients with surgically resected perihilar cholangiocarcinoma.手术切除的肝门部胆管癌患者门静脉侵犯部位的预后影响
Surgery. 2016 Jun;159(6):1511-1519. doi: 10.1016/j.surg.2016.01.012. Epub 2016 Mar 3.
10
Appraisal of inflammation-based prognostic scores in patients with unresectable perihilar cholangiocarcinoma.不可切除性肝门部胆管癌患者基于炎症的预后评分评估
J Hepatobiliary Pancreat Sci. 2016 Oct;23(10):636-642. doi: 10.1002/jhbp.386. Epub 2016 Aug 30.

引用本文的文献

1
Perineural invasion of hilar cholangiocarcinoma in Chinese population: One center's experience.中国人群肝门部胆管癌的神经周围侵犯:单中心经验
World J Gastrointest Oncol. 2020 Apr 15;12(4):457-466. doi: 10.4251/wjgo.v12.i4.457.